Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery

Wang, B. Z., Nash, T. R., Zhang, X., Rao, J., Abriola, L., Kim, Y., Zakharov, S., Kim, M., Luo, L. J., Morsink, M., Liu, B., Lock, R. I., Fleischer, S., Tamargo, M. A., Bohnen, M., Welch, C. L., Chung, W. K., Marx, S. O., Surovtseva, Y. V., … Fine, B. M. (2023). Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery. Cell Reports Medicine, 4(3), 100976. https://doi.org/10.1016/j.xcrm.2023.100976
Authors:
Bryan Z. Wang
Trevor R. Nash
Xiaokan Zhang
Jenny Rao
Laura Abriola
Youngbin Kim
Sergey I. Zakharov
Michael Kim
Lori J. Luo
Margaretha Morsink
Bohao Liu
Roberta Lock
Sharon Fleischer
Manuel A. Tamargo
Michael S. Bohnen
Carrie L. Welch
Wendy K. Chung
Steven O. Marx
Yulia V. Surovtseva
Gordana Vunjak‐Novakovic
Barry Fine
Affiliated Authors:
Bryan Z. Wang
Trevor R. Nash
Xiaokan Zhang
Jenny Rao
Youngbin Kim
Sergey I. Zakharov
Michael Kim
Lori J. Luo
Margaretha Morsink
Bohao Liu
Roberta Lock
Sharon Fleischer
Manuel A. Tamargo
Michael S. Bohnen
Carrie L. Welch
Wendy K. Chung
Steven O. Marx
Gordana Vunjak‐Novakovic
Barry Fine
Author Keywords:
flnc
high throughput drug screen
induced pluripotent stem cell
restrictive cardiomyopathy
tissue engineering
Publication Type:
Article
Unique ID:
10.1016/j.xcrm.2023.100976
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: